December 14, 2017—Hospitals in the 340B drug discount program are ramping up efforts to get Congress to block deep cuts in their Medicare Part B drug payments set to begin Jan. 1. In a Dec. 13 letter to the bipartisan leadership of Congress, 340B Health, which represents more than 1,300 hospitals and health systems in 340B, said the impending cuts “will cause tremendous … [Read more...]
Senator, Patient Advocate Support 340B in Hearing
December 13, 2017—Members of the Senate Health, Education, Labor, and Pensions (HELP) Committee heard a powerful defense of the 340B drug discount program yesterday at a hearing on the new National Academies of Sciences (NAS) report on why medicines cost so much and what can be done about it. The committee’s senior Democratic member, Sen. Patty Murray (D-Wash.), noted that … [Read more...]
Don’t Let CMS Cut 340B Hospital Payments, 32 Hospital Associations Urge Court
December 13, 2017—Thirty-two state and regional hospital associations say many hospitals they represent and scores of low-income, vulnerable, and rural patients the hospitals serve will suffer great harm if a controversial Medicare regulation takes effect on Jan. 1 as planned. … [Read more...]
Senate Hearing Next Week on Outrageous Prescription Drug Prices
December 5, 2017—The Senate Health, Education, Labor and Pensions (HELP) Committee is holding a Dec. 12 hearing on new National Academies of Sciences (NAS) findings on why medicines cost so much and recommendations on how to fix the problem. The NAS’s Nov. 30 report is drawing attention for calling on the federal government to negotiate drugs prices with manufacturers, deny … [Read more...]
Judge Orders Dec. 21 Hearing in Suit to Block Huge Cuts to 340B Hospitals
November 28, 2017—A federal district judge has scheduled a Dec. 21 hearing in the lawsuit seeking to stop drastic Medicare Part B drug reimbursement cuts for many 340B hospitals from taking effect on Jan. 1. … [Read more...]
CMS Finalizes Nearly 30 Percent Cut in Medicare Part B Drug Payments to 340B Hospitals
November 1, 2017—The Centers for Medicare & Medicaid Services late today published a final Outpatient Prospective Payment System (OPPS) regulation that cuts Medicare Part B drug reimbursement to hospitals in the 340B drug discount program for separately payable drugs by nearly 30 percent, from average sales price (ASP) plus 6 percent to ASP minus 22.5 percent. The reduction … [Read more...]
House E&C Oversight Subcommittee 340B Hearing Recap
October 11, 2017—The House Energy & Commerce oversight subcommittee held its second hearing on the 340B program this morning, focusing on how covered entities track and use their savings to improve patient care. Three 340B hospitals and health systems testified – Mission Health (N.C.), The Johns Hopkins Hospital (Md.), and Northside Hospital (Ga.). The committee also heard … [Read more...]